A Case Study on Rheumatoid Arthritis
Keywords:Autoimmune disorder, R.A. factor, Miasmatic diagnosis, Totality of symptoms, E.S.R., C.R.P.
Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints. It typically results in warm, swollen, and painful joints.(cont)Pain and stiffness often worsen following rest. Most commonly, the wrist and hands are involved symmetrically Peak onset age is of 50 ± 15 years, Female: male -3: 1, Old women -5 %. Genetic contribution -30% to 60%. -HLA-DR4 allele in Caucasians is associated with a relative risk of almost 4 for RA. It started as vague pain with gradual appearance without classic symptoms of Joint swelling/tenderness/morning stiffness, effect of small joints, symmetric pattern of involvement, positive compression test is highly suggestive of RA. A case of a 38 years female was taken for its study. The case was taken with its presenting complaints with location, sensation, modality & concomitant. Then treatment history, H/O present complains, past history, family history, personal history was collected. There after physical generals, mental generals, physical examinations & laboratory investigations were done. Case was diagnosed ontologically to be a case of “Rheumatoid arthritis”. Miasmatic assessment was done & determined to be case of “mixed miasmatic disease with preponderance of psoric miasm”. Step by step proceeded from Analysis of symptoms, Conceptual image, Analysis of the case/Synthesis of the case, Evaluation/Repertorial totality to arrive at a “Totality of symptoms”. The case was repertorized and Pulsatilla was evolved as the drug of choice. Hence it was prescribed in 50 millesimal scale followed by Bryonia album in same scale as chronic remedies. During treatment keeping miasm in mind patient was treated. Necessary intercurrents such as Petrolium 200, Medorrhinum 1m was prescribed. Finally, Sulphur 200 1 dose as an anti- psoric as per miasmatic treatment principle was given as finishing dose. Finally, patient was recovered fully.
How to Cite
Copyright (c) 2022 Niranjan Mohanty
This work is licensed under a Creative Commons Attribution 4.0 International License.